View of Exploring the safety of combination therapy with SGLT-2 and DPP-4 inhibitors in type 2 Diabetes mellitus

Return to Article Details Exploring the safety of combination therapy with SGLT-2 and DPP-4 inhibitors in type 2 Diabetes mellitus Download Download PDF